Billy Schrauth
Story Poster
12:08
Nuño's Notes: Irish insiders expect a bounce-back performance in Week 3
13 days ago by David Nuño
Marcus Freeman's Notre Dame Fighting Irish are ranked eighth in the country, but with an early-season loss, the Golden Domers already have their backs up against the wall. Ahead of Texas A&M's trip to South Bend, David Nuño shares what he has gathered from Irish insiders.
Story Poster
Notre Dame relying on new additions to replicate success of 2024
4 mo ago by Olin Buchanan
Notre Dame must replace its quarterback, three starting offensive linemen, two of its top receivers, its top two tacklers and its leader in sacks and interceptions. Even with so many departures, Marcus Freeman's Fighting Irish are projected to be a top-10 team.
Story Poster
New lines likely the difference on Saturday as A&M begins a new era
1 yr ago by Olin Buchanan
Mike Elko represents a new hope for Texas A&M football, but in Saturday's opener against No. 7 Notre Dame, it will likely be the new offensive lines that will decide who emerges victoriously. The "Elko Era" officially kicks off at 6:30 p.m. CT from Kyle Field in Bryan-College Station.
Story Poster
30:50
Elko confident a 'No. 1' receiver will emerge as Aggies open season
1 yr ago by Olin Buchanan
The departures of Ainias Smith and Evan Stewart have casted doubt over the strength of Texas A&M's receiving corps, particularly, whether or not a "No. 1" receiver will rise. Ahead of Saturday's season opener, Mike Elko expressed belief that he does have a go-to wideout.
Story Poster
Rebuilding offensive line primary concern for Notre Dame in 2024
1 yr ago by Olin Buchanan
In order to improve on a 10-3 finish, the Fighting Irish must continue its tradition of fielding a formidable offensive line. Success will also be contingent on Duke transfer quarterback Riley Leonard and their defense — which ranked fifth in 2023 — delivering productive seasons.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.